FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to therapy, and can be used to predict the occurrence of contrast-induced nephropathy (CIN) in patients with acute myocardial infarction (AMI) who underwent coronary angiography (CAG) and percutaneous coronary intervention (PCI). One should identify predictors in patients that are necessary and sufficient to determine the risk of developing CIN: patient age, anemia, the volume of contrast substance per unit of body weight (ml/kg). Then the probability of CIN development is calculated according to the original calculation formula. If CIN development is 0.05 and less than 0.05, the risk of CIN development is low. If CIN development varies from 0.051-0.15, the risk of CIN development is medium. If CIN development is 0.51 and higher than 0.51, the risk of CIN development is high.
EFFECT: invention makes it possible to effectively assess the risk of contrast-induced nephropathy in AMI patients who underwent CAG and PCI.
1 cl, 1 dwg, 4 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF DEVELOPMENT OF ACUTE KIDNEY DAMAGE DURING MYOCARDIAL INFARCTION IN MEN UNDER 60 YEARS | 2022 |
|
RU2784943C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF MASSIVE CORONARY THROMBOSIS OF AN INFARCTION-RESPONSIBLE CORONARY ARTERY IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION | 2022 |
|
RU2792252C1 |
| METHOD FOR IMMUNOLOGICAL PREDICTION OF SMALL MYOCARDIAL DAMAGE | 2014 |
|
RU2585391C1 |
| METHOD FOR OPTIMIZATION OF EARLY IMMUNOLOGICAL DIAGNOSTICS OF COMPLICATIONS OF PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH IHD | 2017 |
|
RU2709458C2 |
| METHOD FOR PREDICTING ADVERSE OUTCOMES UP TO 12 MONTHS IN PATIENTS WITH ACUTE CORONARY SYNDROME | 2020 |
|
RU2747693C1 |
| METHOD OF PREVENTING CONTRAST-INDUCED NEPHROPATHY DURING RADIO-OPAQUE EXAMINATION | 2009 |
|
RU2414896C1 |
| METHOD OF PREDICTION RISK OF ADVERSE CARDIOVASCULAR AND CEREBROVASCULAR EVENTS FOR 6 YEARS AFTER SCHEDULED ENDOVASCULAR MYOCARDIUM REVASCULARIZATION | 2017 |
|
RU2642930C1 |
| METHOD FOR STENT THROMBOSIS PREDICTION IN THE PATIENTS WITH ACUTE CORONARY SYNDROME AFTER A PERCUTANEOUS CORONARY INTERVENTION WITH A BACKGROUND OF DOUBLE ANTIPLATELET THERAPY | 2018 |
|
RU2690892C1 |
| METHOD FOR PREDICTION OF ACUTE KIDNEY INJURY IN PATIENTS WITH ACUTE CORONARY SYNDROME USING A RISK SCALE | 2019 |
|
RU2724017C1 |
| METHOD FOR PREDICTING THE RISK OF LATE FATAL CARDIAC AND CEREBROVASCULAR EVENTS AFTER A PLANNED ENDOVASCULAR MYOCARDIAL REVASCULARIZATION | 2018 |
|
RU2683691C1 |
